EBV-related Hodgkin lymphoma

Clinical trials for EBV-related Hodgkin lymphoma explained in plain language.

Never miss a new study

Get alerted when new EBV-related Hodgkin lymphoma trials appear

Sign up with your email to follow new studies for EBV-related Hodgkin lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Supercharged immune cells take on Hard-to-Treat lymphoma

Disease control Recruiting now

This early-phase trial tests a new type of immune cell therapy for patients with EBV-positive Hodgkin or non-Hodgkin lymphoma that has returned or not responded to standard treatments. The researchers add a gene called C7R to the patient's own T cells to help them survive longer …

Matched conditions: EBV-RELATED HODGKIN LYMPHOMA

Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC

EBV-related Hodgkin lymphoma

Get alerted when new EBV-related Hodgkin lymphoma trials appear

Supercharged immune cells take on Hard-to-Treat lymphoma